Zydus receives tentative approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
There is a fast resurgence in the transplant activities post COVID
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
Data show 37% reduction in risk of disease progression or death in men with metastatic castration-resistant prostate cancer treated with TALZENNA plus XTANDI
Company's Unit - IX, an API intermediate facility situated at Sangareddy District, Telangana, has now been classified as Voluntary Action Indicated
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya
Through this collaboration, the erstwhile Government Maternity Hospital in Kanakapura Taluk has been rebuilt and the new hospital has facilities including oxygen and medical gas pipelines
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
Subscribe To Our Newsletter & Stay Updated